Asthma Trial, Recruiting NCT05768399 Sponsor: Children's Hospital of Chongqing Medical University Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT05768399
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 4 to 12 years old who have been newly diagnosed with bronchial asthma or are experiencing a recurring episode of it
  • Children whose diagnosis meets the official guidelines set out in the 2016 Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children
  • Children who have clear, typical symptoms of the condition and whose medical records and test results are complete
  • A family member or legal guardian must have been fully informed about the research and agreed to take part by signing a consent form
  • Healthy children included as a comparison group must have no history of lung disease, allergic rhinitis, or any other allergy-related condition

Who may not be able to join:

  • Children who have another respiratory condition, such as bronchiectasis, respiratory failure, tuberculosis, or obstructive airway disease, or who have another type of inflammatory disease
  • Children who have abnormal development of the airways or lung tissue that was present from birth
  • Children who have used immune-suppressing medications or steroid medications (such as corticosteroids) within the four weeks before joining the trial
  • Children who have a condition affecting the hormone (endocrine) system or the immune system, other than the condition being studied
  • Children whose medical records or test results are incomplete

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-15178712548

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Hospital of Chongqing Medical University
Registry
ClinicalTrials.gov
Start date
4 July 2023
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The level of biomarkers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov